Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1978 Jan;7(1):28–33. doi: 10.1128/jcm.7.1.28-33.1978

Growth and Amino Acid Requirements of Various Strains of Group B Streptococci

Thomas W Milligan 1, Terence I Doran 1, David C Straus 1, Stephen J Mattingly 1
PMCID: PMC274851  PMID: 342537

Abstract

A chemically defined medium (FMC; B. Terleckyj, N. P. Willett, and G. D. Shockman, Infect. Immun. 11:649-655, 1975) was used to compare the growth and amino acid requirements of 16 strains of group B streptococci, consisting of both laboratory-passaged organisms and fresh clinical isolates from adult and neonatal infections. The 5 standard Lancefield immunizing strains of group B streptococci, 090 (Ia), H36B (Ib), A909 (Ic), 18RS21 (II), and D136C (III), had doubling times in FMC (28 to 36 min) similar to those observed in Todd-Hewitt glucose broth (24 to 30 min). Similar doubling times were obtained with 11 clinical isolates growing in Todd-Hewitt glucose broth and FMC. The optimum buffering capacity of FMC was provided by 0.06 M sodium phosphate, and 1% glucose gave maximum cell yield. The group B streptococci, with minor exceptions, were very homogeneous in their amino acid requirements under both aerobic and anaerobic growth conditions. Phenylalanine, tyrosine, tryptophan, glutamate, arginine, valine, leucine, lysine, methionine, isoleucine, cystine, and histidine were required by all 16 strains under both aerobic and anaerobic growth conditions. In addition, threonine was required by all strains under aerobic growth conditions, whereas only 9 strains required threonine under anaerobic conditions. Serine was required by only 3 type III fresh clinical isolates aerobically, but not anaerobically. A requirement for glycine varied from strain to strain, apparently influenced by the oxidation-reduction potential of the growth medium.

Full text

PDF
28

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker C. J., Barrett F. F. Transmission of group B streptococci among parturient women and their neonates. J Pediatr. 1973 Dec;83(6):919–925. doi: 10.1016/s0022-3476(73)80524-4. [DOI] [PubMed] [Google Scholar]
  2. Baker C. J., Kasper D. L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med. 1976 Apr 1;294(14):753–756. doi: 10.1056/NEJM197604012941404. [DOI] [PubMed] [Google Scholar]
  3. Baker C. J., Kasper D. L. Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus. J Infect Dis. 1977 Aug;136 (Suppl):S98–104. doi: 10.1093/infdis/136.supplement.s98. [DOI] [PubMed] [Google Scholar]
  4. Baker C. J., Kasper D. L. Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun. 1976 Jan;13(1):189–194. doi: 10.1128/iai.13.1.189-194.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Franciosi R. A., Knostman J. D., Zimmerman R. A. Group B streptococcal neonatal and infant infections. J Pediatr. 1973 Apr;82(4):707–718. doi: 10.1016/s0022-3476(73)80604-3. [DOI] [PubMed] [Google Scholar]
  6. Mickelson M. N. Effects of nutritional characteristics of Streptococcus agalactiae on inhibition of growth by lactoperoxidase-thiocyanate-hydrogen peroxide in chemically defined culture medium. Appl Environ Microbiol. 1976 Aug;32(2):238–244. doi: 10.1128/aem.32.2.238-244.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Milligan T. W., Straus D. C., Mattingly S. J. Extracellular neuraminidase production by group B streptococci. Infect Immun. 1977 Oct;18(1):189–195. doi: 10.1128/iai.18.1.189-195.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Terleckyj B., Shockman G. D. Amino acid requirements of Streptococcus mutans and other oral streptococci. Infect Immun. 1975 Apr;11(4):656–664. doi: 10.1128/iai.11.4.656-664.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Terleckyj B., Willett N. P., Shockman G. D. Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun. 1975 Apr;11(4):649–655. doi: 10.1128/iai.11.4.649-655.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Willett N. P., Morse G. E., Carlisle S. A. Requirements for growth of Streptococcus agalactiae in a chemically defined medium. J Bacteriol. 1967 Oct;94(4):1247–1248. doi: 10.1128/jb.94.4.1247-1248.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Willett N. P., Morse G. E. Long-chain fatty acid inhibition of growth of Streptococcus agalactiae in a chemically defined medium. J Bacteriol. 1966 Jun;91(6):2245–2250. doi: 10.1128/jb.91.6.2245-2250.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES